Drug Master Files for: ABBVIE
✉ Email this page to a colleague
ABBVIE Drug Master Files
| DMF No. | Status | Type | Submission Date | Holder | Subject |
|---|---|---|---|---|---|
| 13197 | A | II | 4/30/1998 | ABBVIE INC | ERYTHROMYCIN BASE |
| 13372 | A | II | 9/1/1998 | ABBVIE INC | ERYTHROMYCIN STEARATE |
| 13443 | A | II | 9/1/1998 | ABBVIE INC | ERYTHROMYCIN ETHYLSUCCINATE |
| 13703 | I | II | 9/1/1998 | ABBVIE INC | CLINDAMYCIN PHOSPHATE |
| 13800 | A | II | 9/1/1998 | ABBVIE INC | CYCLOSPORINE USP |
| 14200 | I | II | 9/1/1998 | ABBVIE INC | ERYTHROMYCIN BASE |
| 14640 | I | II | 12/22/1999 | ABBVIE INC | 5-DESOSAMINYL-6-0-METHYL ERYTHRONOLIDE |
| >DMF No. | >Status | >Type | >Submission Date | >Holder | >Subject |
Drug Master File Glossary
STATUS OF DMFS
- A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
- I = Inactive
- N = Not an assigned number
- P = DMF Pending Filing Review
TYPES OF DMFs
- Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
- Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
- Type III Packaging Material
- Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
- Type V FDA Accepted Reference Information
